Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Direktor, Klinik für Nuklearmedizin
Aktuelle Veranstaltungen
-
2022 SS
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (PV)
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen für höhere Semester (mit Patientenvorstellung) (PV)
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen (Nuklearmedizin und Strahlentherapie) für höhere Semester (mit Patientenvorstellung) (*)
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz Teil III (WA)
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Systematische Befundung in der Nuklearmedizin
- Radiologische Klinik für klinischen Studienabschnitt: Diagnostische Radiologie
- Ringvorlesung: Tumordiagnostik (mit Patientenvorstellung) (*)
- Wahlfach: Einführung in die Nuklearmedizin
- PJ - Seminar
- Kardiologisch-nuklearmedizinische Falldemonstrationen (*)
- Klinische Nuklearmedizin: Grundlagen und Indikationen
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 3
- Wahlfach: Klinische Nuklearmedizin
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil III (PV)
- Multimodale Bildgebung (PET/CT, PET/MRT, SPECT/CT)
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil I (PV)
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (WA) begleitende Vorlesung zum Kurs
- Der nuklearmedizinische Fall der Woche: Bildbeispiele, Indikationen und Grundlagen
- Kursus für Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil I (WA) (begleitende Vorlesung zum Kurs)
Vergangene Veranstaltungen (max. 10)
-
2021 WS
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen für höhere Semester (mit Patientenvorstellung) (PV)
- Kursus für bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz, Teil II (PV)
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 1
- Diagnostik, Therapie und Therapieplanung mit ionisierenden Strahlen (Nuklearmedizin und Strahlentherapie) für höhere Semester (mit Patientenvorstellung) (*)
- begl. Vorlesung: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Ringvorlesung: Tumordiagnostik (mit Patientenvorstellung) (*)
- Kurs: Bildgebende Verfahren, Strahlenbehandlung, Strahlenschutz - Teil 2
- Anleitung zu selbständigen wissenschaftlichen Arbeiten in der Nuklearmedizin
- Systematische Befundung in der Nuklearmedizin
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
18F-FDG PET/CT Imaging Biomarkers for Early and Late Evaluation of Response to First-Line Chemotherapy in Patients with Pancreatic Ductal AdenocarcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 2, S. 199 - 204
ISSN: 1535-5667; 0022-3123Online Volltext: dx.doi.org/ (Open Access) -
A Role for PET/CT in response assessment of malignant pleural mesotheliomaIn: Seminars in Nuclear Medicine (2022) in press
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
A Role of PET/MR in Breast Cancer?In: Seminars in Nuclear Medicine (2022) in press
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90 : the TARGET studyIn: European Journal of Nuclear Medicine and Molecular Imaging (2022) in press
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access) -
COVID-19 Pandemic : What Have We Learned and What to Expect in the Future?In: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 1, S. 86 - 89
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ (Open Access) -
Chaperone Therapy in Fabry DiseaseIn: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 3,
ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ (Open Access) -
Clinical Use of PET/MR in Oncology : An UpdateIn: Seminars in Nuclear Medicine Jg. 52 (2022) Nr. 3, S. 356 - 364
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
Comparison of nodal staging between CT, MRI, and [¹⁸F]-FDG PET/MRI in patients with newly diagnosed breast cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 992 - 1001
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosisIn: Annals of Clinical and Translational Neurology (2022) in press
ISSN: 2328-9503Online Volltext: dx.doi.org/ (Open Access) -
Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with PheochromocytomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 6, S. 869 - 874
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ -
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compoundsIn: European Journal of Nuclear Medicine and Molecular Imaging (2022) in press
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access) -
First experiences with dynamic renal [⁶⁸Ga]Ga-DOTA PET/CT : A comparison to renal scintigraphy and compartmental modelling to non-invasively estimate the glomerular filtration rateIn: European Journal of Nuclear Medicine and Molecular Imaging (2022) in press
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access) -
Free-breathing 3D Stack of Stars GRE (StarVIBE) sequence for detecting pulmonary nodules in 18F-FDG PET/MRIIn: EJNMMI Physics Jg. 9 (2022) Nr. 1,
ISSN: 2197-7364Online Volltext: dx.doi.org/ (Open Access) -
Hybrid total-body pet scanners : current status and future perspectivesIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) S. 445 - 459
ISSN: 1619-7089; 1619-7070; 1432-105X; 0340-6997Online Volltext: dx.doi.org/ (Open Access) -
Imaging the Inflammatory Response in Checkpoint Inhibition MyocarditisIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 14 - 16
ISSN: 1535-5667; 2159-662XOnline Volltext: dx.doi.org/ -
Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineIn: Nuklearmedizin = Nuclear Medicine (2022) in press
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ (Open Access) -
Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors : A Case Series of 9 PatientsIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 727 - 734
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ -
Joint EANM, SNMMI and IAEA enabling guide : How to set up a theranostics centreIn: European Journal of Nuclear Medicine and Molecular Imaging (2022) in press
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access) -
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2022) Nr. 4, S. 1386 - 1406
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access) -
Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanomaIn: Cancer Imaging Jg. 22 (2022) Nr. 1,
ISSN: 1470-7330; 1740-5025Online Volltext: dx.doi.org/ (Open Access) -
Multiparametric¹⁸F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast CancerIn: Cancers Jg. 14 (2022) Nr. 7,
ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access) -
PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups : An International Multicenter StudyIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 1, S. 76 - 80
ISSN: 1535-5667; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG-PET/CT external beam radiation treatment planning in lung cancerIn: Radiotherapy and Oncology (The Green Journal) Jg. 168 (2022) S. 37 - 39
ISSN: 1879-0887; 0167-8140Online Volltext: dx.doi.org/ (Open Access) -
Quantitative ⁹⁹mTc-DPD-SPECT/CT assessment of cardiac amyloidosisIn: Journal of Nuclear Cardiology (2022) in press
ISSN: 1532-6551; 1071-3581Online Volltext: dx.doi.org/ (Open Access) -
Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor VolumeIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 746 - 753
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ -
Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell CarcinomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 3, S. 396 - 398
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ -
Shining Damaged Hearts : Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear CardiologyIn: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 7,
ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ (Open Access) -
Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapyIn: Endocrine Jg. 75 (2022) Nr. 1, S. 293 - 302
ISSN: 1559-0100; 1355-008X; 0969-711XOnline Volltext: dx.doi.org/ (Open Access) -
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal Jg. 43 (2022) Nr. 4, S. 316 - 329
ISSN: 0195-668X; 1522-9645Online Volltext: dx.doi.org/ -
The Future Role of PET Imaging in Metastatic Breast CancerIn: Oncology Research and Treatment Jg. 45 (2022) Nr. 1-2, S. 18 - 25
ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Training on Reporting and Data System (RADS) for Somatostatin-Receptor Targeted Molecular Imaging Can Reduce the Test Anxiety of Inexperienced ReadersIn: Molecular Imaging and Biology (2022) in press
ISSN: 1860-2002; 1536-1632Online Volltext: dx.doi.org/ (Open Access) -
Tumor Sink Effect in ⁶⁸Ga-PSMA-11 PET : Myth or Reality?In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 2, S. 226 - 232
ISSN: 1535-5667; 2159-662X; 0022-3123; 0097-9058; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Virtual Biopsy : Just an AI Software or a Medical Procedure?In: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 4, S. 511 - 513
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ Online Volltext (Open Access) -
[⁶⁸Ga]/[⁹⁰Y]FAPI-46 : Automated production and analytical validation of a theranostic pairIn: Nuclear Medicine and Biology Jg. 110-111 (2022) S. 37 - 44
ISSN: 1872-9614; 0969-8051Online Volltext: dx.doi.org/ -
¹⁸F-FLT PET/CT as a Prognostic Imaging Biomarker of Disease-Specific Survival in Patients with Primary Soft-Tissue SarcomaIn: Journal of Nuclear Medicine (JNM) Jg. 63 (2022) Nr. 5, S. 708 - 712
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ -
¹⁸F-flutemetamol positron emission tomography in cardiac amyloidosisIn: Journal of Nuclear Cardiology Jg. 29 (2022) Nr. 2, S. 779 - 789
ISSN: 1532-6551; 1071-3581Online Volltext: dx.doi.org/ (Open Access) -
An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastasesIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 5, S. 1522 - 1537
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Analysis of risk factors and prognosis in differentiated thyroid cancer with focus on minimal extrathyroidal extensionIn: BMC Endocrine Disorders Jg. 21 (2021) Nr. 1,
ISSN: 1472-6823Online Volltext: dx.doi.org/ (Open Access) -
Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancerIn: European Journal of Hybrid Imaging Jg. 5 (2021) Nr. 1,
ISSN: 2510-3636Online Volltext: dx.doi.org/ (Open Access) -
Auswirkungen von COVID-19 auf nuklearmedizinische Untersuchungen und Therapien im Verlauf von 2020 : Ergebnisse einer nationalen UmfrageIn: Nuklearmedizin Jg. 60 (2021) Nr. 3, S. 210 - 215
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ -
Bone Metastases Are Measurable : The Role of Whole-Body MRI and Positron Emission TomographyIn: Frontiers in Oncology Jg. 11 (2021)
ISSN: 2234-943XOnline Volltext: dx.doi.org/ (Open Access) -
Can a ToF-PET photon attenuation reconstruction test stopping-power estimations in proton therapy? : A phantom studyIn: Physics in Medicine and Biology Jg. 66 (2021) Nr. 21,
ISSN: 0031-9155; 1361-6560Online Volltext: dx.doi.org/ -
Changes in the global impact of COVID-19 on nuclear medicine departments during 2020 : An international follow-up surveyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 13, S. 4318 - 4330
ISSN: 1619-7089; 1619-7070; 1432-105X; 0340-6997Online Volltext: dx.doi.org/ (Open Access) -
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerIn: EJNMMI Physics Jg. 8 (2021) Nr. 1, S. 14
ISSN: 2197-7364Online Volltext: dx.doi.org/ (Open Access) -
Comparison of pre- and post-contrast-enhanced attenuation correction using a CAIPI-accelerated T1-weighted Dixon 3D-VIBE sequence in ⁶⁸Ga-DOTATOC PET/MRIIn: European Journal of Radiology (EJR) Jg. 139 (2021) S. 109691
ISSN: 1872-7727; 0720-048XOnline Volltext: dx.doi.org/ -
Complete metabolic response in patients with advanced nonsmall cell lung cancer with prolonged response to immune checkpoint inhibitor therapyIn: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 3, S. 002262
ISSN: 2051-1426Online Volltext: dx.doi.org/ (Open Access) -
Consensus on molecular imaging and theranostics in neuroendocrine neoplasmsIn: European Journal of Cancer Jg. 146 (2021) S. 56 - 73
ISSN: 1879-0852; 0959-8049Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 2, S. 469 - 476
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Correlation between contrast enhancement, standardized uptake value (SUV), and diffusion restriction (ADC) with tumor grading in patients with therapy-naive neuroendocrine neoplasms using hybrid ⁶⁸Ga-DOTATOC PET/MRIIn: European Journal of Radiology Jg. 137 (2021) S. 109588
ISSN: 1872-7727; 0720-048XOnline Volltext: dx.doi.org/ -
Correlation of the apparent diffusion coefficient (ADC) and standardized uptake values (SUV) with overall survival in patients with primary non-small cell lung cancer (NSCLC) using ¹⁸F-FDG PET/MRIIn: European Journal of Radiology Jg. 134 (2021) S. 109422
ISSN: 1872-7727; 0720-048XOnline Volltext: dx.doi.org/ (Open Access) -
Determining the Axillary Nodal Status with 4 Current Imaging Modalities, Including 18F-FDG PET/MRI, in Newly Diagnosed Breast Cancer : A Comparative Study Using Histopathology as the Reference StandardIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1677 - 1683
ISSN: 0161-5505; 1535-5667Online Volltext: dx.doi.org/ -
Diagnostic Accuracy of ⁶⁸Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging TrialIn: JAMA Oncology Jg. 7 (2021) Nr. 11, S. 1635 - 1642
ISSN: 2374-2445; 2374-2437Online Volltext: dx.doi.org/ -
Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease : A meta-analysisIn: Endocrine Connections Jg. 10 (2021) Nr. 3, S. 358 - 370
ISSN: 2049-3614Online Volltext: dx.doi.org/ (Open Access) -
Diagnostic performance of kwak, eu, acr, and korean tirads as well as ata guidelines for the ultrasound risk stratification of non-autonomously functioning thyroid nodules in a region with long history of iodine deficiency : A German multicenter trialIn: Cancers Jg. 13 (2021) Nr. 17,
ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access) -
Digital and respiratory-gated FDG PET/CT for characterization of lung lesionsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 83
ISSN: 1619-7070; 1619-7089 -
Direct proton range verification using oxygen-18 enriched water as a contrast agentIn: Radiation Physics and Chemistry Jg. 182 (2021)
ISSN: 1879-0895; 0969-806XOnline Volltext: dx.doi.org/ (Open Access) -
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus : mature results of a phase I/II trialIn: Radiation Oncology Jg. 16 (2021) Nr. 1, S. 59
ISSN: 1748-717XOnline Volltext: dx.doi.org/ (Open Access) -
Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancerIn: Nuclear Medicine and Biology Jg. 96-97 (2021) S. 101 - 111
ISSN: 1872-9614; 0969-8051Online Volltext: dx.doi.org/ (Open Access) -
E-PSMA : The EANM standardized reporting guidelines v1.0 for PSMA-PETIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 5, S. 1626 - 1638
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 67 - 72
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Enzalutamide enhances psma expression of psma-low prostate cancerIn: International Journal of Molecular Sciences (IJMS) Jg. 22 (2021) Nr. 14,
ISSN: 1422-0067; 1661-6596Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) : Pancreatic CancerIn: Cancer Treatment Reviews Jg. 99 (2021)
ISSN: 1532-1967; 0305-7372Online Volltext: dx.doi.org/ (Open Access) -
Evaluation of [⁶⁸Ga]Ga-PSMA PET/CT images acquired with a reduced scan time duration in prostate cancer patients using the digital biograph visionIn: EJNMMI Research Jg. 11 (2021) Nr. 1, S. 21
ISSN: 2191-219XOnline Volltext: dx.doi.org/ (Open Access) -
Evaluation of a new automated assay for high-sensitivity thyroglobulin measurement and comparison with two established high-sensitivity thyroglobulin assaysIn: Practical Laboratory Medicine Jg. 26 (2021)
ISSN: 2352-5517Online Volltext: dx.doi.org/ (Open Access) -
Evaluation of the Diagnostic Performance of Positron Emission Tomography/Magnetic Resonance for the Diagnosis of Liver MetastasesIn: Investigative Radiology Jg. 56 (2021) Nr. 10, S. 621 - 628
ISSN: 0020-9996; 1536-0210Online Volltext: dx.doi.org/ -
Evaluation of the predictive potential of 18F-FDG PET and DWI data sets for relevant prognostic parameters of primary soft-tissue sarcomasIn: Cancers Jg. 13 (2021) Nr. 11,
ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access) -
Evaluation of ¹⁸F-FDG PET and DWI Datasets for Predicting Therapy Response of Soft-Tissue Sarcomas Under Neoadjuvant Isolated Limb PerfusionIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 3, S. 348 - 353
ISSN: 1535-5667; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Evaluation of ¹⁸F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph visionIn: BMC Cancer Jg. 21 (2021) Nr. 1,
ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access) -
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL>60 trialsIn: European Journal of Nuclear Medicine and Molecular Imaging (2021) in press
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL>60 trialsIn: European Journal of Nuclear Medicine and Molecular Imaging (2021) in press
ISSN: 0340-6997; 1619-7089Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
FDG-PET avidity as a prognostic biomarker for overall survival in renal cell carcinomaIn: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. Suppl. 15, S. e16564
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
FDG-PET/CT Variants and Pitfalls in Haematological MalignanciesIn: Seminars in Nuclear Medicine Jg. 51 (2021) Nr. 6, S. 554 - 571
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
Fabry Cardiomyopathy : Current Treatment and Future OptionsIn: Journal of Clinical Medicine Jg. 10 (2021) Nr. 14,
ISSN: 2077-0383Online Volltext: dx.doi.org/ (Open Access) -
Factors predicting biochemical response and survival benefits following radioligand therapy with [¹⁷⁷Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer : A reviewIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 12, S. 4028 - 4041
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 2, S. 501 - 508
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging : A Multicenter Retrospective StudyIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 5, S. 675 - 678
ISSN: 0022-3123; 1535-5667Online Volltext: dx.doi.org/ (Open Access) -
Imaging Inflammation with Positron Emission TomographyIn: Biomedicines Jg. 9 (2021) Nr. 2, S. 212
ISSN: 2227-9059Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Impact of EBUS-TBNA in addition to [¹⁸F]FDG-PET/CT imaging on target volume definition for radiochemotherapy in stage III NSCLCIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2894 - 2903
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
In vivo targeting of cxcr4 : new horizonsIn: Cancers Jg. 13 (2021) Nr. 23,
ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access) -
Insights into immunometabolism : A dataset correlating the ¹⁸FDG PET/CT maximum standard uptake value of the primary tumor with the CCL18 serum level in non-small cell lung cancerIn: Data in Brief Jg. 35 (2021) S. 106859
ISSN: 2352-3409Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Irène Buvat and Ken Herrmann Talk with Alexander Stremitzer, Kevin Tobia, and Aileen NielsenIn: Journal of Nuclear Medicine Jg. 62 (2021) Nr. 1, S. 3 - 5
ISSN: 1535-5667; 2159-662X; 0161-5505; 0097-9058; 0022-3123Online Volltext: dx.doi.org/ (Open Access) -
Just another “Clever Hans”? : Neural networks and FDG PET-CT to predict the outcome of patients with breast cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 10, S. 3141 - 3150
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: The New England Journal of Medicine Jg. 385 (2021) S. 1091 - 1103
ISSN: 1533-4406; 0028-4793Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Machine learning-based differentiation between multiple sclerosis and glioma WHO II°-IV° using O-(2-[18F] fluoroethyl)-L-tyrosine positron emission tomographyIn: Journal of Neuro-Oncology Jg. 152 (2021) S. 325 - 332
ISSN: 1573-7373; 0167-594XOnline Volltext: dx.doi.org/ -
Mental health burden of german cancer patients before and after the outbreak of covid-19 : Predictors of mental health impairmentIn: International Journal of Environmental Research and Public Health = IJERPH Jg. 18 (2021) Nr. 5,
ISSN: 1660-4601; 1661-7827Online Volltext: dx.doi.org/ (Open Access) -
Multiparametric integrated¹⁸f-fdg pet/mri-based radiomics for breast cancer phenotyping and tumor decodingIn: Cancers Jg. 13 (2021) Nr. 12,
ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access) -
N-staging in large cell neuroendocrine carcinoma of the lung : diagnostic value of [¹⁸F]FDG PET/CT compared to the histopathology reference standardIn: EJNMMI Research Jg. 11 (2021) Nr. 1,
ISSN: 2191-219XOnline Volltext: dx.doi.org/ (Open Access) -
New PET technologies : embracing progress and pushing the limitsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 2711 - 2726
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Nomograms to predict outcomes after ¹⁷⁷Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer : An international, multicentre, retrospective studyIn: The Lancet Oncology Jg. 22 (2021) Nr. 8, S. 1115 - 1125
ISSN: 1474-5488; 1470-2045Online Volltext: dx.doi.org/ (Open Access) -
Novel CYP11B-ligand [¹²³/¹³¹I]IMAZA as promising theranostic tool for adrenocortical tumors : Comprehensive preclinical characterization and first clinical experienceIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 49 (2021) S. 301 - 310
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Nuclear medicine theranostics comes of ageIn: The Lancet Oncology Jg. 22 (2021) Nr. 11, S. 1497 - 1498
ISSN: 1474-5488; 1470-2045Online Volltext: dx.doi.org/ -
Oldies (but Goldies) : Die Peritonealszintigrafie bei PeritonealdialyseIn: Nuklearmedizin Jg. 60 (2021) Nr. 06, S. 450 - 453
ISSN: 0029-5566; 2567-6407Online Volltext: dx.doi.org/ -
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [¹⁷⁷Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysisIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. 4, S. 1200 - 1210
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access) -
PSMA-PET for the assessment of metastatic hormone-sensitive prostate cancer volume of diseaseIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1747 - 1750
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ -
PSMA-ligand PET for early castration-resistant prostate cancer : a retrospective single-center studyIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 1, S. 88 - 91
ISSN: 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Patterns of nodal spread in stage III NSCLC : Importance of EBUS-TBNA and ¹⁸F-FDG PET/CT for radiotherapy target volume definitionIn: Radiation Oncology Jg. 16 (2021) Nr. 1,
ISSN: 1748-717XOnline Volltext: dx.doi.org/ (Open Access) -
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : study protocolIn: BMC Cancer Jg. 21 (2021)
ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access) -
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment : A Systematic ReviewIn: European Urology Oncology Jg. 4 (2021) Nr. 5, S. 714 - 730
ISSN: 2588-9311Online Volltext: dx.doi.org/ -
Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 eraIn: European Journal of Cancer (EJC) Jg. 144 (2021) S. 200 - 214
ISSN: 1879-0852; 0959-8049Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCIn: Cancers Jg. 13 (2021) Nr. 7, S. 1728
ISSN: 2072-6694Online Volltext: dx.doi.org/ (Open Access) -
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non-Small Cell Lung Cancer Patients Receiving Definitive ChemoradiotherapyIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 12, S. 1684 - 1691
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ Online Volltext (Open Access) -
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast CancerIn: Clinical Nuclear Medicine Jg. 46 (2021) Nr. 3, S. 201 - 205
ISSN: 0363-9762; 1536-0229Online Volltext: dx.doi.org/ -
Prospective comparison of CT and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patients : Initial resultsIn: PLoS ONE Jg. 16 (2021)
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patientsIn: European Radiology Jg. 31 (2021) Nr. 11, S. 8714 - 8724
ISSN: 1432-1084; 0938-7994Online Volltext: dx.doi.org/ (Open Access) -
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC) : efficacy results of the UCLA cohortIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 10, S. 1440 - 1446
ISSN: 1535-5667; 2159-662XOnline Volltext: dx.doi.org/ Online Volltext (Open Access) -
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfallsIn: Translational Andrology and Urology Jg. 10 (2021) Nr. 10, S. 3972 - 3985
ISSN: 2223-4691; 2223-4683Online Volltext: dx.doi.org/ (Open Access) -
Prostate-specific Membrane Antigen–based Imaging of Castration-resistant Prostate CancerIn: European Urology Focus Jg. 7 (2021) Nr. 2, S. 279 - 287
ISSN: 2405-4569Online Volltext: dx.doi.org/ -
Radioembolization With Chemotherapy for Colorectal Liver Metastases : A Randomized, Open-Label, International, Multicenter, Phase III TrialIn: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 35, S. 3897 - 3907
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ (Open Access) -
Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: European Urology Jg. 80 (2021) Nr. 4, S. 520 - 521
ISSN: 1873-7560; 0302-2838Online Volltext: dx.doi.org/ -
Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617 : Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 10, S. 1447 - 1456
ISSN: 1535-5667; 2159-662XOnline Volltext: dx.doi.org/ Online Volltext (Open Access) -
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124In: Scientific Reports Jg. 11 (2021) Nr. 1,
ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access) -
The Disappearing Act of Nuclear Medicine in The Netherlands : Just a New Trick by the Great Harry Houdini?In: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 7, S. 903 - 904
ISSN: 1535-5667; 2159-662X; 0022-3123; 0097-9058; 0161-5505Online Volltext: dx.doi.org/ -
The influence of ⁶⁸Ga-prostate-specific membrane antigen PET/computed tomography on prostate cancer staging and planning of definitive radiation therapyIn: Nuclear Medicine Communications Jg. 42 (2021) Nr. 7, S. 811 - 817
ISSN: 1473-5628; 0143-3636Online Volltext: dx.doi.org/ -
The salivary glands as a dose limiting organ of PSMA- targeted radionuclide therapy : A review of the lessons learnt so farIn: Nuclear Medicine and Biology Jg. 98-99 (2021) S. 30 - 39
ISSN: 1872-9614; 0969-8051Online Volltext: dx.doi.org/ (Open Access) -
Theranostics in Boron neutron capture therapyIn: Life Jg. 11 (2021) Nr. 4, S. 330
ISSN: 2075-1729Online Volltext: dx.doi.org/ (Open Access) -
Thymic hyperplasia after mRNA based Covid-19 vaccinationIn: Radiology Case Reports Jg. 16 (2021) Nr. 12, S. 3744 - 3745
ISSN: 1930-0433Online Volltext: dx.doi.org/ (Open Access) -
Towards using secondary gamma-rays from proton-induced radioactivation of titanium implants for off-line field verificationIn: Nuclear Instruments and Methods in Physics Research: Section B, Beam interactions with materials and atoms Jg. 492 (2021) S. 56 - 63
ISSN: 0168-583X; 1872-9584Online Volltext: dx.doi.org/ -
Volumetric PET Response Assessment Outperforms Conventional Criteria in Patients Receiving High-Dose Pembrolizumab for Malignant MesotheliomaIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 2, S. 191 - 194
ISSN: 1535-5667; 0097-9058; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsIn: Oncology Research and Treatment Jg. 44 (2021) Nr. 7-8, S. 400 - 407
ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ (Open Access) -
[⁶⁸Ga]Ga-PSMA-11 PET/CT improves tumor detection and impacts management in patients with hepatocellular carcinomaIn: Journal of Nuclear Medicine Jg. 62 (2021) Nr. 9, S. 1235 - 1241
ISSN: 0022-3123; 0161-5505Online Volltext: dx.doi.org/ -
18F-FDG PET/MR versus MR Alone in Whole-Body Primary Staging and Restaging of Patients with Rectal Cancer : What Is the Benefit of PET?In: Journal of Clinical Medicine Jg. 9 (2020) Nr. 10, S. 3163
ISSN: 2077-0383Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
A conversation between Ignasi Carrió and Ken HerrmannIn: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 5, S. 638 - 640
ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
AU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort : Under the Auspices of the EAU-ESMO Guidelines CommitteesIn: European Urology Jg. 77 (2020) Nr. 2, S. 223 - 250
ISSN: 1873-7560; 0302-2838Online Volltext: dx.doi.org/ (Open Access) -
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand TherapyIn: Theranostics Jg. 10 (2020) Nr. 17, S. 7812 - 7820
ISSN: 1838-7640Online Volltext: dx.doi.org/ (Open Access) -
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapyIn: Medicine Jg. 99 (2020) Nr. 38, S. e22287
ISSN: 1536-5964; 0025-7974Online Volltext: dx.doi.org/ (Open Access) -
Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [¹⁸F]FDG PET/CT and [¹⁸F]FDG PET/MRIIn: Nuclear Medicine and Molecular Imaging Jg. 54 (2020) Nr. 4, S. 183 - 191
ISSN: 1869-3482; 1869-3474Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
COVID-19-Related Fear and Health-Related Safety Behavior in Oncological PatientsIn: Frontiers in Psychology Jg. 11 (2020) S. 1984
ISSN: 1664-1078Online Volltext: dx.doi.org/ (Open Access) -
Can the injected dose be reduced in ⁶⁸Ga-PSMA-11 PET/CT while maintaining high image quality for lesion detection?In: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 2, S. 189 - 193
ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Cardiac PET/MRI : Current Clinical Status and Future PerspectivesIn: Seminars in Nuclear Medicine Jg. 50 (2020) Nr. 3, S. 260 - 269
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationIn: Lung Cancer Jg. 139 (2020) S. 165 - 168
ISSN: 1872-8332; 0169-5002Online Volltext: dx.doi.org/ -
Comparison of acceptance of PET/MR enterography and ileocolonoscopy in patients with inflammatory bowel diseasesIn: Clinical Imaging Jg. 64 (2020) S. 11 - 17
ISSN: 1873-4499; 0899-7071Online Volltext: dx.doi.org/ -
Comparison of ¹⁸F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitisIn: The British Journal of Radiology (BJR) Jg. 93 (2020) Nr. 1112, S. 20200167
ISSN: 1748-880X; 0007-1285Online Volltext: dx.doi.org/ (Open Access) -
Coronavirus SARS-CoV-2 : Empfehlungen für die nuklearmedizinische Versorgung in nuklearmedizinischen Kliniken/Abteilungen mit Therapiestation und Praxen, Instituten sowie OrdinationenIn: Nuklearmedizin = Nuclear Medicine Jg. 59 (2020) Nr. 2, S. E1 - E4
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ (Open Access) -
Correction for hyperfunctioning radiation-induced stunning (CHRIS) in benign thyroid diseasesIn: Endocrine Jg. 69 (2020) Nr. 2, S. 466 - 473
ISSN: 1559-0100; 1355-008X; 0969-711XOnline Volltext: dx.doi.org/ -
Correction to: Nuclear medicine services after COVID-19: gearing up back to normalityIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 9, S. 2220
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines CommitteesIn: European Urology Jg. 78 (2020) Nr. 1, S. e48 - e50
ISSN: 1873-7560; 0302-2838Online Volltext: dx.doi.org/ (Open Access) -
Diagnosis and screening of patients with fabry diseaseIn: Therapeutics and Clinical Risk Management Jg. 16 (2020) S. 551 - 558
ISSN: 1178-203X; 1176-6336Online Volltext: dx.doi.org/ (Open Access) -
Diagnostic Performance of Simultaneous [18F]-FDG PET/MR for Assessing Endoscopically Active Inflammation in Patients with Ulcerative Colitis : A Prospective StudyIn: Journal of Clinical Medicine Jg. 9 (2020) Nr. 8, S. 2474
ISSN: 2077-0383Online Volltext: dx.doi.org/ (Open Access) -
Efficacy and Safety of ¹⁷⁷Lu-labeled Prostate-specific Membrane Antigen Radionuclide Treatment in Patients with Diffuse Bone Marrow Involvement : A Multicenter Retrospective StudyIn: European Urology Jg. 78 (2020) Nr. 2, S. 148 - 154
ISSN: 1873-7560; 0302-2838Online Volltext: dx.doi.org/ -
Evaluation of improved attenuation correction in whole-body PET/MR on patients with bone metastasis using various radiotracersIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 10, S. 2269 - 2279
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11In: European Journal of Nuclear Medicine and Molecular Imaging (2020)
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Global impact of COVID-19 on nuclear medicine departments : An international survey in April 2020In: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 9, S. 1278 - 1283
ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Imaging inflammation after myocardial infarction : implications for prognosis and therapeutic guidanceIn: Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 64 (2020) Nr. 1, S. 35 - 50
ISSN: 1827-1936; 1824-4785Online Volltext: dx.doi.org/ -
Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal CarcinoidsIn: Endocrine Pathology Jg. 31 (2020) S. 101 - 107
ISSN: 1559-0097; 1046-3976Online Volltext: dx.doi.org/ (Open Access) -
Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialIn: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 12, S. 1793 - 1799
ISSN: 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland : An International Survey in April 2020In: Nuklearmedizin Jg. 59 (2020) Nr. 4, S. 294 - 299
ISSN: 2567-6407Online Volltext: dx.doi.org/ -
Impact of ¹⁸F-FDG PET/MR on therapeutic management in high risk primary breast cancer patients : A prospective evaluation of staging algorithmsIn: European Journal of Radiology Jg. 128 (2020) S. 108975
ISSN: 1872-7727; 0720-048XOnline Volltext: dx.doi.org/ -
In vivo biodistribution of calcium phosphate nanoparticles after intravascular, intramuscular, intratumoral, and soft tissue administration in mice investigated by small animal PET/CTIn: Acta Biomaterialia Jg. 109 (2020) S. 244 - 253
ISSN: 1878-7568; 1742-7061Online Volltext: dx.doi.org/ -
Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy : A feasibility studyIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 10, S. 1500 - 1506
ISSN: 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ Online Volltext (Open Access) -
Is there a connection between immunohistochemical markers and grading of lung cancer with apparent diffusion coefficient (ADC) and standardised uptake values (SUV) of hybrid 18F-FDG-PET/MRI?In: Journal of Medical Imaging and Radiation Oncology Jg. 64 (2020) Nr. 6, S. 779 - 786
ISSN: 1754-9485; 1754-9477Online Volltext: dx.doi.org/ -
Joint Imaging Platform for Federated Clinical Data AnalyticsIn: JCO Clinical Cancer Informatics Jg. 4 (2020) S. 1027 - 1038
ISSN: 2473-4276Online Volltext: dx.doi.org/ (Open Access) -
Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-HybridbildgebungIn: Nuklearmedizin Jg. 59 (2020) Nr. 4, S. 288 - 293
ISSN: 2567-6407Online Volltext: dx.doi.org/ (Open Access) -
Konsensusempfehlung zur strukturierten Befunderstellung onkologischer PET-Hybridbildgebung*In: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren Jg. 192 (2020) Nr. 8, S. 739 - 744
ISSN: 1438-9010; 1438-9029Online Volltext: dx.doi.org/ (Open Access) -
Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients : a meta-analysisIn: BMC Cancer Jg. 20 (2020) Nr. 1,
ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access) -
Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 8, S. 1871 - 1884
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PETIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 7, S. 1037 - 1042
ISSN: 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ Online Volltext (Open Access) -
Molecular Imaging and Therapy of Colorectal and Anal CancerIn: Seminars in Nuclear Medicine Jg. 50 (2020) Nr. 5, S. 465 - 470
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
Molecular imaging and theranosticsIn: Der Onkologe Jg. 26 (2020) Nr. 1, S. 14 - 21
ISSN: 1433-0415; 0947-8965Online Volltext: dx.doi.org/ -
Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapyIn: The Lancet Oncology Jg. 21 (2020) Nr. 9, S. e431 - e443
ISSN: 1474-5488; 1470-2045Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Neuroendokrine Neoplasien des VerdauungstraktsIn: Best Practice Onkologie Jg. 15 (2020) Nr. 7-8, S. 320 - 333
ISSN: 1862-8559; 0946-4565Online Volltext: dx.doi.org/ -
Non-invasive tumor decoding and phenotyping of cerebral gliomas utilizing multiparametric ¹⁸F-FET PET-MRI and MR FingerprintingIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 6, S. 1435 - 1445
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Nuclear medicine and molecular imaging advances in the 21st centuryIn: The British Journal of Radiology (BJR) Jg. 93 (2020) Nr. 1110, S. 20200095
ISSN: 1748-880X; 0007-1285Online Volltext: dx.doi.org/ -
Nuclear medicine operations in the times of COVID-19: Strategies, precautions, and experiencesIn: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 5, S. 626 - 629
ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
PET/MRI Versus PET/CT for Whole-Body Staging : Results from a Single-Center Observational Study on 1,003 Sequential ExaminationsIn: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 8, S. 1131 - 1136
ISSN: 1535-5667; 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic : Are There Any Concerns?In: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 8, S. 1094 - 1095
ISSN: 1535-5667; 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 RadioembolizationIn: Journal of Clinical Medicine Jg. 9 (2020) Nr. 1, S. 56
ISSN: 2077-0383Online Volltext: dx.doi.org/ (Open Access) -
Prospective evaluation of whole-body MRI and ¹⁸F-FDG PET/MRI in N and M staging of primary breast cancer patientsIn: European Journal of Nuclear Medicine and Molecular Imaging (2020)
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Prostate-specific membrane antigen targeted PET imaging for prostate cancer recurrenceIn: Current Opinion in Urology Jg. 30 (2020) Nr. 5, S. 635 - 640
ISSN: 1473-6586; 0963-0643Online Volltext: dx.doi.org/ -
Publisher Correction to: 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosisIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3196
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical CancerIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren Jg. 192 (2020) Nr. 8, S. 754 - 763
ISSN: 1438-9010; 1438-9029Online Volltext: dx.doi.org/ (Open Access) -
Radionuklidtherapie mit PSMA-Liganden bei fortgeschrittenem ProstatakarzinomIn: Der Urologe Jg. 59 (2020) Nr. 6, S. 680 - 686
ISSN: 1433-0563; 0340-2592Online Volltext: dx.doi.org/ -
Radiotheranostics : A roadmap for future developmentIn: The Lancet Oncology Jg. 21 (2020) Nr. 3, S. e146 - e156
ISSN: 1474-5488; 1470-2045Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Re: Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Prostate Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA) : A Prospective, Randomised, Multi-centre StudyIn: European Urology Jg. 78 (2020) Nr. 3, S. 470 - 471
ISSN: 1873-7560; 0302-2838Online Volltext: dx.doi.org/ -
Semi-automatically quantified tumor volume using Ga-68-PSMA-11-PET as biomarker for survival in patients with advanced prostate cancerIn: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 12, S. 1786 - 1792
ISSN: 0161-5505; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Textural analysis of hybrid DOTATOC-PET/MRI and its association with histological grading in patients with liver metastases from neuroendocrine tumorsIn: Nuclear Medicine Communications Jg. 41 (2020) Nr. 4, S. 363 - 369
ISSN: 1473-5628; 0143-3636Online Volltext: dx.doi.org/ -
The Future of Nuclear Medicine, Molecular Imaging, and TheranosticsIn: Journal of Nuclear Medicine Jg. 61 (2020) Nr. Supplement 2, S. 263S - 272S
ISSN: 1535-5667; 2159-662X; 0097-9058Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRIIn: Radiology Jg. 296 (2020) Nr. 1, S. 143 - 151
ISSN: 1527-1315; 0033-8419Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Treatment-related changes in neuroendocrine tumors as assessed by textural features derived from ⁶⁸Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficientIn: BMC Cancer Jg. 20 (2020) Nr. 1,
ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access) -
Whole-Body Integrated [⁶⁸Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer : Comparison with Whole-Body PET/CT as the Standard of ReferenceIn: Molecular Imaging and Biology Jg. 22 (2020) Nr. 3, S. 788 - 796
ISSN: 1860-2002; 1536-1632Online Volltext: dx.doi.org/ -
¹⁸F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis : A randomized controlled trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 4, S. 768 - 777
ISSN: 1619-7089; 1619-7070; 1432-105X; 0340-6997Online Volltext: dx.doi.org/ -
¹⁸F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitisIn: PLoS ONE Jg. 15 (2020) Nr. 1, S. e0227906
ISSN: 1932-6203Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
¹⁸F-florbetaben positron computed tomography detects cardiac involvement in systemic AA amyloidosisIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 13, S. 3186 - 3187
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
“COVID-19 Pandemic as stimulator to Re-Establish Nuclear Medicine as Clinical Specialty” based on a report of Prof. Dr. Ignasi CarrioIn: Nuklearmedizin: Molecular imaging and therapy Jg. 59 (2020) Nr. 6, S. 405 - 408
ISSN: 0029-5566; 2567-6407Online Volltext: dx.doi.org/ -
18F-FDG PET/MRI for Therapy Response Assessment of Isolated Limb Perfusion in Patients with Soft-Tissue SarcomasIn: Journal of Nuclear Medicine (JNM) Jg. 60 (2019) Nr. 11, S. 1537 - 1542
ISSN: 1535-5667; 0161-5505; 2159-662X; 0097-9058; 0022-3123Online Volltext: dx.doi.org/ (Open Access) -
A conversation between Stefano Buono and Ken HerrmannIn: Journal of Nuclear Medicine Jg. 60 (2019) Nr. 12, S. 1659 - 1662
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
A conversation between Susanne Schaffert and Ken HerrmannIn: Journal of Nuclear Medicine Jg. 60 (2019) Nr. 7, S. 875 - 878
ISSN: 1535-5667; 0161-5505; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Assessment of ⁶⁸ Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialIn: JAMA Oncology Jg. 5 (2019) Nr. 6, S. 856 - 863
ISSN: 2374-2445; 2374-2437Online Volltext: dx.doi.org/ (Open Access) -
Assessment of ileocolonic inflammation in Crohn’s disease : Which surrogate marker is better—MAria, Clermont, or PET/MR index? Initial results of a feasibility trialIn: Journal of Nuclear Medicine Jg. 60 (2019) Nr. 6, S. 851 - 857
ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Cardiac PET/MRI—an updateIn: European Journal of Hybrid Imaging Jg. 3 (2019) Nr. 1,
ISSN: 2510-3636Online Volltext: dx.doi.org/ (Open Access) -
Changing trends of incidence and prognosis of thyroid carcinomaIn: Nuklearmedizin = Nuclear Medicine Jg. 58 (2019) Nr. 2, S. 86 - 92
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ -
Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed GliomaIn: Clinical Nuclear Medicine Jg. 44 (2019) Nr. 6, S. e375 - e381
ISSN: 1536-0229; 0363-9762Online Volltext: dx.doi.org/ -
Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumorsIn: Theranostics Jg. 9 (2019) S. 2924 - 2938
ISSN: 1838-7640Online Volltext: dx.doi.org/ -
Driving the Future of Nuclear MedicineIn: Journal of Nuclear Medicine Jg. 60 (2019) Nr. 9, S. 1S - 2S
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
EANM procedure guidelines for radionuclide therapy with ¹⁷⁷Lu-labelled PSMA-ligands (¹⁷⁷Lu-PSMA-RLT)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 12, S. 2536 - 2544
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines CommitteesIn: Annals of Oncology Jg. 30 (2019) Nr. 11, S. 1697 - 1727
ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ (Open Access) -
Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer after Prostatectomy in a Multicenter Retrospective StudyIn: The Journal of Urology Jg. 202 (2019) Nr. 6, S. 1174 - 1181
ISSN: 1527-3792; 0022-5347Online Volltext: dx.doi.org/ -
In vitro and in vivo characterization of an ¹⁸F-ALF-labeled PSMA ligand for imaging of PSMA-expressing xenograftsIn: Journal of Nuclear Medicine Jg. 60 (2019) Nr. 7, S. 1017 - 1022
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Molecular Imaging for Primary Staging of Prostate CancerIn: Seminars in Nuclear Medicine Jg. 49 (2019) Nr. 4, S. 271 - 279
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
Morphologische Diagnosekriterien der nichtinvasiven follikulären Neoplasie mit PTC-äquivalenten Kernmerkmalen (NIFTP) : Eine diagnostische Herausforderung zum Nutzen des PatientenIn: Der Pathologe Jg. 40 (2019) Nr. 3, S. 220 - 226
ISSN: 0172-8113; 1432-1963Online Volltext: dx.doi.org/ -
NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 RadioembolizationIn: Liver Cancer Jg. 8 (2019) Nr. 6, S. 491 - 504
ISSN: 2235-1795; 1664-5553Online Volltext: dx.doi.org/ -
Novel structured reporting systems for theranostic radiotracersIn: Journal of Nuclear Medicine Jg. 60 (2019) Nr. 5, S. 577 - 584
ISSN: 1535-5667; 0161-5505; 0022-3123; 0097-9058Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Nuklearmedizinische Diagnostik der SarkoidoseIn: Atemwegs- und Lungenkrankheiten Jg. 45 (2019) Nr. 12, S. 573 - 580
ISSN: 0341-3055Online Volltext: dx.doi.org/ -
PET/MR Imaging of the Female PelvisIn: Seminars in Nuclear Medicine Jg. 49 (2019) Nr. 6, S. 512 - 520
ISSN: 1558-4623; 0001-2998Online Volltext: dx.doi.org/ -
PSA-Anstieg nach definitiver TherapieIn: Der Urologe Jg. 58 (2019) Nr. 5, S. 569 - 582
ISSN: 1433-0563; 0340-2592Online Volltext: dx.doi.org/ -
Post-radiosynovectomy imaging utilizing Erbium-169 citrateIn: Applied Radiation and Isotopes Jg. 154 (2019)
ISSN: 0969-8043; 1872-9800Online Volltext: dx.doi.org/ -
Pretreatment metabolic tumour volume in stage IIIA/B non-small-cell lung cancer uncovers differences in effectiveness of definitive radiochemotherapy schedules : analysis of the ESPATUE randomized phase 3 trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 7, S. 1439 - 1447
ISSN: 1619-7089; 1619-7070; 0340-6997Online Volltext: dx.doi.org/ -
Production of [¹¹C]Formaldehyde by the XeF2 mediated oxidation of [¹¹C]Methanol and its application in the labeling of α-(N-[¹¹C]Methylamino)isobutyric acidIn: Applied Radiation and Isotopes Jg. 148 (2019) S. 178 - 183
ISSN: 1872-9800; 0969-8043Online Volltext: dx.doi.org/ -
Prognostic Value of Metabolic Tumor Volume after Induction Chemotherapy in Stage IIIA/B Non-Small-Cell Lung Cancer : Secondary Analysis of a Randomized Phase 3 TrialIn: International Journal of Radiation Oncology, Biology, Physics Jg. 105 (2019) Nr. 1, Supplement, S. 146 - S147
ISSN: 1879-355XOnline Volltext: dx.doi.org/ (Open Access) -
Prospective comparison of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT for thoracic staging of non-small cell lung cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) Nr. 2, S. 437 - 445
ISSN: 1619-7089; 1619-7070; 0340-6997Online Volltext: dx.doi.org/ -
Prostate-specific membrane antigen ligand positron emission tomography in men with nonmetastatic castration-resistant prostate cancerIn: Clinical Cancer Research Jg. 25 (2019) Nr. 24, S. 7448 - 7454
ISSN: 1557-3265; 1078-0432Online Volltext: dx.doi.org/ (Open Access) -
Reply by AuthorsIn: Journal of Urology Jg. 202 (2019) Nr. 6, S. 1181
ISSN: 1527-3792; 0022-5347Online Volltext: dx.doi.org/ -
Sentinel lymph node excision with or without preoperative hybrid single-photon emission computed tomography/computed tomography (SPECT/CT) in melanoma : Study protocol for a multicentric randomized controlled trialIn: Trials Jg. 20 (2019) Nr. 1, S. 99
ISSN: 1745-6215Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
The beginning of the end for conventional RECIST — novel therapies require novel imaging approachesIn: Nature Reviews Clinical Oncology Jg. 16 (2019) Nr. 7, S. 442 - 458
ISSN: 1759-4774; 1759-4782Online Volltext: dx.doi.org/ -
The role of 124I PET/CT lesion dosimetry in differentiated thyroid cancerIn: The Quarterly Journal of Nuclear Medicine and Molecular Imaging Jg. 63 (2019) Nr. 3, S. 235 - 252
ISSN: 1827-1936; 0392-0208; 1824-4785Online Volltext: dx.doi.org/ -
Theranostics for Advanced Prostate Cancer : Current Indications and Future DevelopmentsIn: European Urology Oncology Jg. 2 (2019) Nr. 2, S. 152 - 162
ISSN: 2588-9311Online Volltext: dx.doi.org/ -
Theranostik von soliden Tumoren : Renaissance eines alten KonzeptsIn: Best Practice Onkologie Jg. 14 (2019) Nr. 12, S. 526 - 534
ISSN: 0946-4565Online Volltext: dx.doi.org/ -
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseasesIn: Endocrine Jg. 63 (2019) Nr. 3, S. 537 - 544
ISSN: 1559-0100; 1355-008X; 0969-711XOnline Volltext: dx.doi.org/ -
Whole-Body [18F]-FDG-PET/MRI for Oncology : A Consensus RecommendationIn: Nuklearmedizin = Nuclear Medicine Jg. 191 (2019) Nr. 2, S. 68 - 76
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ (Open Access) -
Whole-Body [18F]-FDG-PET/MRI for oncology : a consensus recommendationIn: RöFo: Fortschritte auf dem Gebiet der Röntgenstrahlen und der Bildgebenden Verfahren Jg. 191 (2019) Nr. 4, S. 289 - 297
ISSN: 1438-9029; 1438-9010Online Volltext: dx.doi.org/ (Open Access) -
[⁶⁸Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate CancerIn: Molecular Imaging and Biology Jg. 21 (2019) Nr. 3, S. 574 - 581
ISSN: 1860-2002; 1536-1632Online Volltext: dx.doi.org/ -
11C-MET PET/MRI for detection of recurrent gliomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 4, S. 593 - 601
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
18F-fluorothymidine PET for predicting survival in patients with resectable pancreatic cancerIn: OncoTarget Jg. 9 (2018) Nr. 11, S. 10128 - 10134
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumorsIn: Journal of Nuclear Medicine Jg. 59 (2018) Nr. 1, S. 66 - 74
ISSN: 2159-662X; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Ascertaining F18 positron-emission tomography skill in glioma classification pursuant to the revised WHO classification 2016In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. S354 - S355
ISSN: 1619-7070; 1619-7089 -
CUP syndrome : Metastatic malignancy with unknown primary tumorIn: Deutsches Ärzteblatt international Jg. 115 (2018) Nr. 10, S. 157 - 162
ISSN: 1866-0452Online Volltext: dx.doi.org/ (Open Access) -
Characterization of site-specifically conjugated monomethyl auristatin E-and duocarmycin-based anti-PSMA antibody-drug conjugates for treatment of PSMA-expressing tumorsIn: Journal of Nuclear Medicine Jg. 59 (2018) Nr. 3, S. 494 - 501
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 65
ISSN: 1619-7070; 1619-7089 -
Comparison of the clinical performance of upper abdominal PET/DCE-MRI with and without concurrent respiratory motion correction (MoCo)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 12, S. 2147 - 2154
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervixIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 1, S. 67 - 76
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Comparison of ¹⁸F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer : a follow-up studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 4, S. 622 - 629
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Comparison of ⁶⁸Ga-PSMA-11 and ¹⁸F-Fluciclovine PET/CT in a case series of 10 patients with prostate cancer recurrenceIn: Journal of Nuclear Medicine Jg. 59 (2018) Nr. 5, S. 789 - 794
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Consensus on molecular imaging and theranostics in prostate cancerIn: The Lancet Oncology Jg. 19 (2018) Nr. 12, S. e696 - e708
ISSN: 1470-2045; 1474-5488Online Volltext: dx.doi.org/ -
Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 176
ISSN: 1619-7070; 1619-7089 -
Detection Threshold and Reproducibility of ⁶⁸Ga-PSMA11 PET/CT in a Mouse Model of Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 9, S. 1392 - 1397
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)In: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. 15 Suppl., S. e15121
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Dual‐phase hybrid 18F‐Fluoride Positron emission tomography/MRI in ankylosing spondylitis : Investigating the link between MRI bone changes, regional hyperaemia and increased osteoblastic activityIn: Journal of Medical Imaging and Radiation Oncology Jg. 62 (2018) Nr. 3, S. 313 - 319
ISSN: 1754-9485; 1754-9477Online Volltext: dx.doi.org/ -
Evaluation of a fast protocol for staging patients with bronchial cancer using PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 200
ISSN: 1619-7070; 1619-7089 -
Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCCIn: Hepatology Jg. 68 (2018) Nr. Suppl. 1, S. 852A - 853A
ISSN: 0270-9139; 1527-3350 -
Impact of Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical RecurrenceIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 3, S. 434 - 441
ISSN: 0161-5505; 1535-5667Online Volltext: dx.doi.org/ (Open Access) -
Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124 i PET/CT imagingIn: Nuclear Medicine Communications Jg. 39 (2018) Nr. 12, S. 1156 - 1164
ISSN: 0143-3636; 1473-5628Online Volltext: dx.doi.org/ -
Inflammation focus search with 18F-FDG-PET/MRI : comparative or additive value of PET and MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. S259 - S260
ISSN: 1619-7070; 1619-7089 -
Integrated ⁶⁸Gallium Labelled Prostate-Specific Membrane Antigen-11 Positron Emission Tomography/Magnetic Resonance Imaging Enhances Discriminatory Power of Multi-Parametric Prostate Magnetic Resonance ImagingIn: Urologia Internationalis Jg. 100 (2018) Nr. 2, S. 164 - 171
ISSN: 0042-1138; 1423-0399Online Volltext: dx.doi.org/ -
Intraindividual comparison of subsequently performed PET/MRI to PET/CT for whole-body staging : Results of a unicenter trial in 1000 patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. S210 - S211
ISSN: 1619-7070; 1619-7089 -
Local and whole-body staging in patients with primary breast cancer : a comparison of one-step to two-step staging utilizing ¹⁸F-FDG-PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 13, S. 2328 - 2337
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Local and whole-body staging in patients with primary breast cancer : A comparison of one-step to two-step-staging utilizing F-18-FDG-PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 456
ISSN: 1619-7070; 1619-7089 -
Lutetium-177-PSMA-Radioligandentherapie : Konsensus im Rahmen der GKV-finanzierten Versorgung zwischen den Hochschulkliniken in Aachen, Bonn, Düsseldorf, Essen und Köln und dem MDK NordrheinIn: Der Urologe Jg. 57 (2018) Nr. 6, S. 709 - 713
ISSN: 1433-0563; 0340-2592Online Volltext: dx.doi.org/ -
MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyIn: Clinical Lung Cancer Jg. 19 (2018) Nr. 4, S. e441 - e463
ISSN: 1938-0690; 1525-7304Online Volltext: dx.doi.org/ -
Microscale radiosynthesis, preclinical imaging and dosimetry study of [¹⁸F]AMBF₃-TATE : A potential PET tracer for clinical imaging of somatostatin receptorsIn: Nuclear Medicine and Biology Jg. 61 (2018) S. 36 - 44
ISSN: 1872-9614; 0969-8051Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Potential impact of ⁶⁸Ga-PSMA-11 PET/CT on the planning of definitive radiation therapy for prostate cancerIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 11, S. 1714 - 1721
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancerIn: EJNMMI Research Jg. 8 (2018) S. 96
ISSN: 2191-219XOnline Volltext: dx.doi.org/ (Open Access) -
Pretherapeutic 124 i dosimetry reliably predicts intratherapeutic blood kinetics of 131 i in patients with differentiated thyroid carcinoma receiving high therapeutic activitiesIn: Nuclear Medicine Communications Jg. 39 (2018) Nr. 5, S. 457 - 464
ISSN: 1473-5628; 0143-3636Online Volltext: dx.doi.org/ -
Prostate cancer molecular imaging standardized evaluation (PROMISE) : Proposed miTNM classification for the interpretation of PSMA-ligand PET/CTIn: Journal of Nuclear Medicine Jg. 59 (2018) Nr. 3, S. 469 - 478
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Quantitative performance evaluation of I PET/MRI lesion dosimetry in differentiated thyroid cancerIn: Physics in Medicine & Biology Jg. 63 (2018) Nr. 1, S. 015014
ISSN: 0031-9155; 1361-6560Online Volltext: dx.doi.org/ -
Quantitative performance of ¹²⁴I PET/MR of neck lesions in thyroid cancer patients using ¹²⁴I PET/CT as referenceIn: EJNMMI Physics Jg. 5 (2018) Nr. 1, S. 13
ISSN: 2197-7364Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Reply : Comparison of Ga-PSMA-11 and F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its WayIn: Journal of Nuclear Medicine (JNM) Jg. 59 (2018) Nr. 5, S. 861
ISSN: 0161-5505; 1535-5667Online Volltext: dx.doi.org/ (Open Access) -
Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients : preliminary resultsIn: Clinical Imaging Jg. 49 (2018) S. 163 - 168
ISSN: 1873-4499; 0899-7071Online Volltext: dx.doi.org/ -
Strategies and technical challenges for imaging oligometastatic disease : Recommendations from the European Organisation for Research and Treatment of Cancer imaging groupIn: European Journal of Cancer Jg. 91 (2018) S. 153 - 163
ISSN: 0964-1947; 0959-8049Online Volltext: dx.doi.org/ -
Targeting CXCR4 (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenomaIn: Hypertension Jg. 71 (2018) Nr. 2, S. 317 - 325
ISSN: 1524-4563; 0194-911XOnline Volltext: dx.doi.org/; Online Volltext: dx.doi.org/ (Open Access) -
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields : initial experienceIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 9, S. 1626 - 1635
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer : a consensus recommendation from the EORTC Imaging GroupIn: The Lancet Oncology Jg. 19 (2018) Nr. 10, S. e534 - e545
ISSN: 1470-2045; 1474-5488Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
[¹⁸F]FDG PET/MR enterography for the assessment of inflammatory activity in Crohn’s disease: comparison of different MRI and PET parametersIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. 8, S. 1382 - 1393
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
⁶⁸Ga-PSMA-11 PET/CT mapping of prostate cancer biochemical recurrence after radical prostatectomy in 270 patients with a PSA level of less than 1.0 ng/mL : Impact on salvage radiotherapy planningIn: Journal of Nuclear Medicine Jg. 59 (2018) Nr. 2, S. 230 - 237
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
(18)F-FDG PET/MRI in patients suffering from lymphoma : how much MRI information is really needed?In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 6, S. 1005 - 1013
ISSN: 1619-7070; 1619-7089; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ -
177Lu-PSMA Radioligand Therapy for Prostate CancerIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 8, S. 1196 - 1200
ISSN: 0161-5505; 2159-662X; 0097-9058; 0022-3123; 1535-5667Online Volltext: dx.doi.org/ (Open Access) -
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.In: PLoS ONE Jg. 12 (2017) Nr. 7, S. e0180349
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography May Exclude Malignancy in Sonographically Suspicious and Scintigraphically Hypofunctional Thyroid Nodules and Reduce Unnecessary Thyroid SurgeriesIn: Thyroid Jg. 27 (2017) Nr. 10, S. 1300 - 1306
ISSN: 1050-7256; 1557-9077Online Volltext: dx.doi.org/ -
68Ga-DOTATATE PET/CT Interobserver Agreement for Neuroendocrine Tumor Assessment : Results of a Prospective Study on 50 PatientsIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 2, S. 307 - 311
ISSN: 0161-5505; 0097-9058; 0022-3123; 2159-662X; 1535-5667Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
68Ga-PSMA PET/CT : Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 6, S. 1014 - 1024
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ -
68Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments : An International Multicenter Prospective StudyIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 10, S. 1617 - 1623
ISSN: 0161-5505; 2159-662X; 0097-9058; 0022-3123; 1535-5667Online Volltext: dx.doi.org/ -
A PET for All Seasons : 18F-Fluorodeoxyglucose to Characterize Inflammation and Malignancy in Retroperitoneal Fibrosis?In: European Urology Jg. 71 (2017) Nr. 6, S. 934 - 935
ISSN: 0302-2838; 1873-7560; 1421-993XOnline Volltext: dx.doi.org/ -
CXCR4 ligands : The next big hit?In: Journal of Nuclear Medicine Jg. 58 (2017) Nr. Suppl. 2, S. 77S - 82S
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ -
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple MyelomaIn: Theranostics Jg. 7 (2017) Nr. 6, S. 1589 - 1597
ISSN: 1838-7640Online Volltext: dx.doi.org/ (Open Access) -
Cholinergic activity and levodopa-induced dyskinesia: a multitracer molecular imaging studyIn: Annals of Clinical and Translational Neurology Jg. 4 (2017) Nr. 9, S. 632 - 639
ISSN: 2328-9503Online Volltext: dx.doi.org/ (Open Access) -
Current Concepts in 68Ga-DOTATATE Imaging of Neuroendocrine Neoplasms : Interpretation, Biodistribution, Dosimetry, and Molecular StrategiesIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 11, S. 1718 - 1726
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Diagnostic accuracy of 18F–FDG PET/CT and MR imaging in patients with adenoid cystic carcinomaIn: BMC Cancer Jg. 17 (2017) Nr. 1, S. 887
ISSN: 1471-2407Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate CancerIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. 11, S. 1786 - 1792
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Evaluation of 68Ga-DOTATOC PET/MRI for whole-body staging of neuroendocrine tumours in comparison with 68Ga-DOTATOC PET/CTIn: European Radiology Jg. 27 (2017) Nr. 10, S. 4091 - 4099
ISSN: 1432-1084; 0938-7994Online Volltext: dx.doi.org/ -
From NETTER to PETTER : PSMA-Targeted radioligand therapyIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 1, S. 9 - 10
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ -
Human Biodistribution and Radiation Dosimetry of 18F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage PathwayIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 3, S. 374 - 378
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ -
Imaging children suffering from lymphoma : an evaluation of different ; 18F-FDG PET/MRI protocols compared to whole-body DW-MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 10, S. 1742 - 1750
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ -
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachIn: Theranostics Jg. 7 (2017) Nr. 6, S. 1489 - 1498
ISSN: 1838-7640Online Volltext: dx.doi.org/ (Open Access) -
Integrated 18F–FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas : a comparison trialIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 11, S. 1823 - 1831
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer PatientsIn: Clinical Nuclear Medicine Jg. 42 (2017) Nr. 1, S. e29 - e34
ISSN: 0363-9762; 1536-0229Online Volltext: dx.doi.org/ -
Most of the Intended Management Changes After 68Ga-DOTATATE PET/CT Are ImplementedIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 11, S. 1793 - 1796
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 1535-5667Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
Neuroendocrine Tumors of the Gastrointestinal TractIn: Visceral Medicine Jg. 33 (2017) Nr. 5, S. 368 - 371
ISSN: 2297-475X; 2297-4725; 1662-6664; 0177-9990; 1662-6672; 1421-9808Online Volltext: dx.doi.org/ (Open Access) -
PSMA ligands for PET imaging of prostate cancerIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 10, S. 1545 - 1552
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ -
PSMA ligands in prostate cancer – Probe optimization and theranostic applicationsIn: Methods: A Companion to Methods in Enzymology Jg. 130 (2017) S. 42 - 50
ISSN: 1095-9130; 1046-2023Online Volltext: dx.doi.org/ -
Prostate-specific membrane antigen ligands for imaging and therapyIn: Journal of Nuclear Medicine (JNM) Jg. 58 (2017) Nr. Suppl. 2, S. 67S - 76S
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ -
Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer : Absorbed Dose in Normal Organs and Tumor LesionsIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 3, S. 445 - 450
ISSN: 0161-5505; 0097-9058; 0022-3123; 2159-662X; 1535-5667Online Volltext: dx.doi.org/ (Open Access) -
Re: Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-ligand-PET/CT Before Salvage Lymph Node Dissection for Recurrent Prostate CancerIn: European Urology Jg. 72 (2017) Nr. 3, S. 470 - 471
ISSN: 0302-2838; 1421-993XOnline Volltext: dx.doi.org/ -
Response assessment of bevacizumab therapy in GBM with integrated 11C-MET-PET/MRI : a feasibility studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. 8, S. 1285 - 1295
ISSN: 1619-7089; 1619-7070; 1432-105X; 0340-6997Online Volltext: dx.doi.org/ -
Targeting CXCR4 with [68Ga]Pentixafor : A suitable theranostic approach in pleural mesothelioma?In: OncoTarget Jg. 8 (2017) Nr. 57, S. 96732 - 96737
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
The impact of somatostatin receptor-directed PET/CT on the management of patients with neuroendocrine tumor : A systematic review and meta-analysisIn: Journal of Nuclear Medicine Jg. 58 (2017) Nr. 5, S. 756 - 761
ISSN: 1535-5667; 0161-5505; 0097-9058; 0022-3123; 2159-662XOnline Volltext: dx.doi.org/ (Open Access) -
Therapy assessment in prostate cancer using choline and PSMA PET/CTIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 44 (2017) Nr. Suppl. 1, S. S78 - S83
ISSN: 1619-7070; 1619-7089; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ -
Whitening and Impaired Glucose Utilization of Brown Adipose Tissue in a Rat Model of Type 2 Diabetes MellitusIn: Scientific Reports Jg. 7 (2017) Nr. 1, S. 16795
ISSN: 2045-2322Online Volltext: dx.doi.org/ (Open Access) -
Whole-body staging of female patients with recurrent pelvic malignancies : Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CTIn: PLoS ONE Jg. 12 (2017) Nr. 2, S. e0172553
ISSN: 1932-6203Online Volltext: dx.doi.org/ (Open Access) -
[68Ga]Pentixafor-PET/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma - Comparison to [18F]FDG and laboratory valuesIn: Theranostics Jg. 7 (2017) Nr. 1, S. 205 - 212
ISSN: 1838-7640Online Volltext: dx.doi.org/ (Open Access) -
¹¹C-Methionine-PET in Multiple Myeloma : A Combined Study from Two Different InstitutionsIn: Theranostics Jg. 7 (2017) Nr. 11, S. 2956 - 2964
ISSN: 1838-7640Online Volltext: dx.doi.org/ (Open Access) -
(68)Ga-labeled Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Imaging : The New Kid on the Block-Early or Too Early to Draw Conclusions?In: European Urology Jg. 70 (2016) Nr. 6, S. 938 - 940
ISSN: 0302-2838Online Volltext: dx.doi.org/ -
First-in-human experience of CXCR4-directed endoradiotherapy with ¹⁷⁷Lu-and ⁹⁰Y-labeled pentixather in advanced-stage multiple myeloma with extensive intra-and extramedullary diseaseIn: Journal of Nuclear Medicine (JNM) Jg. 57 (2016) Nr. 2, S. 248 - 251
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ -
Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomyIn: EJNMMI Research Jg. 6 (2016) Nr. 1, S. 78
ISSN: 2191-219XOnline Volltext: dx.doi.org/ (Open Access) -
Initial Preclinical Evaluation of 18F-Fluorodeoxysorbitol PET as a Novel Functional Renal Imaging AgentIn: Journal of Nuclear Medicine (JNM) Jg. 57 (2016) Nr. 10, S. 1625 - 1628
ISSN: 0161-5505; 1535-5667Online Volltext: dx.doi.org/ -
Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancerIn: Expert Review of Molecular Diagnostics Jg. 16 (2016) Nr. 11, S. 1177 - 1188
ISSN: 1473-7159; 1744-8352Online Volltext: dx.doi.org/ -
The incidence of thyroid cancer in focal hypermetabolic thyroid lesions : an 18F-FDG PET/CT study in more than 6000 patientsIn: Nuclear Medicine Communications Jg. 37 (2016) Nr. 12, S. 1290 - 1296
ISSN: 0143-3636Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
¹¹C-methionine-PET in multiple myeloma : Correlation with clinical parameters and bone marrow involvementIn: Theranostics Jg. 6 (2016) Nr. 2, S. 254 - 261
ISSN: 1838-7640Online Volltext: dx.doi.org/ (Open Access) -
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myelomaIn: EMBO Molecular Medicine Jg. 7 (2015) Nr. 4, S. 477 - 487
ISSN: 1757-4684; 1757-4676Online Volltext: dx.doi.org/ (Open Access) -
¹¹C-Methionine-PET : A novel and sensitive tool for monitoring of early response to treatment in multiple myelomaIn: OncoTarget Jg. 6 (2015) Nr. 10, S. 8418 - 8429
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
Somatostatin receptor expression in Merkel cell carcinoma as target for molecular imagingIn: BMC Cancer Jg. 14 (2014) Nr. 1,
ISSN: 1471-2407Online Volltext: dx.doi.org/ (Open Access) -
¹⁸FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantationIn: OncoTarget Jg. 5 (2014) Nr. 17, S. 7381 - 7391
ISSN: 1949-2553Online Volltext: dx.doi.org/ (Open Access) -
A genome-wide RNAi screen identifies proteins modulating aberrant FLT3-ITD signalingIn: Leukemia Jg. 27 (2013) Nr. 12, S. 2301 - 2310
ISSN: 1476-5551Online Volltext: dx.doi.org/ -
Correction to: Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[¹⁸F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0 (European Journal of Nuclear Medicine and Molecular Imaging, (2022), 49, 4, (1386-1406), 10.1007/s00259-021-05624-5)In: European Journal of Nuclear Medicine and Molecular Imaging (2022) in press
ISSN: 1619-7089; 1619-7070; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ (Open Access) -
Correction: Individualized treatment of differentiated thyroid cancer : The value of surgery in combination with radioiodine imaging and therapy - A German position paper from Surgery and Nuclear MedicineIn: Nuklearmedizin = Nuclear Medicine (2022) in press
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ -
Re: Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate CancerIn: TheJournal of Urology Jg. 207 (2022) Nr. 2, S. 467 - 468
ISSN: 1527-3792; 0022-5347Online Volltext: dx.doi.org/ -
2021: the year [¹⁷⁷Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to “A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands” by Dr. Germo GerickeIn: European Journal of Nuclear Medicine and Molecular Imaging (2021)
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ Online Volltext (Open Access) -
EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours—the consensus in a nutshellIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) S. 1276 - 1277
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Kamingespräch § 13 (2b) AMG in der nuklearmedizinischen Therapie : Eine Follow-up-Veranstaltung der NuklearMedizin 2020 - DigitalIn: Nuklearmedizin Jg. 60 (2021) Nr. 4, S. 262 - 263
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ -
Nuclear Medicine Beyond VISIONIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 7, S. 916 - 917
ISSN: 1535-5667; 2159-662X; 0022-3123; 0097-9058; 0161-5505Online Volltext: dx.doi.org/ (Open Access) -
Real-World Data as an Evidence Source in Nuclear MedicineIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. 2, S. 156 - 157
ISSN: 0161-5505; 2159-662X; 1535-5667Online Volltext: dx.doi.org/ -
COVID-19 pandemic : guidance for nuclear medicine departmentsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 7, S. 1615 - 1619
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
HybridbildgebungIn: Der Radiologe Jg. 60 (2020) Nr. 5, S. 375
ISSN: 0033-832XOnline Volltext: dx.doi.org/ -
Influence of androgen deprivation therapy on PSMA expression and PSMA-ligand PET imaging of prostate cancer patientsIn: European Journal of Nuclear Medicine & Molecular Imaging: Official journal of the European Association of Nuclear Medicine (EANM) Jg. 47 (2020) Nr. 1, S. 9 - 15
ISSN: 1619-7089; 1619-7070; 1432-105X; 0340-6997Online Volltext: dx.doi.org/ (Open Access) -
Metabolic response assessment and PET-guided treatment of esophageal cancerIn: Annals of Oncology Jg. 31 (2020) Nr. 2, S. 163 - 164
ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ -
Nuclear medicine services after COVID-19: gearing up back to normalityIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 9, S. 2048 - 2053
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging : The PSMA PET Progression CriteriaIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. 5, S. 678 - 682
ISSN: 1535-5667; 2159-662X; 0022-3123; 0097-9058; 0161-5505Online Volltext: dx.doi.org/ -
Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across EuropeIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. 6, S. 1335 - 1339
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ (Open Access) -
Caveat Emptor : Let our acclaim of the apotheosis of PRRT not blind us to the error of PrometheusIn: Journal of Nuclear Medicine Jg. 60 (2019) Nr. 1, S. 7 - 8
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ -
EJNMMI supplement : bringing AI and radiomics to nuclear medicineIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 46 (2019) S. 2627 - 2629
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Zukunftsworkshop 1.0 : Aufbruch in die Zukunft oder ein Strohfeuer?In: Nuklearmedizin = Nuclear Medicine Jg. 58 (2019) Nr. 4, S. 297 - 300
ISSN: 2567-6407; 0029-5566Online Volltext: dx.doi.org/ -
PrefaceIn: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.) (2018) S. vii
ISBN: 9783319696416; 9783319696409Online Volltext: dx.doi.org/ -
Theranostic concepts: More than just a fashion trend-introduction and overviewIn: Journal of Nuclear Medicine Jg. 58 (2017) S. 1S - 2S
ISSN: 1535-5667; 0161-5505Online Volltext: dx.doi.org/ -
A Conversation Between Christoph Zindel and Ken HerrmannIn: Journal of Nuclear Medicine Jg. 61 (2020) Nr. 8, S. 1088 - 1090
ISSN: 1535-5667; 2159-662X; 0161-5505Online Volltext: dx.doi.org/ -
Dosimetry of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer : Results from the VISION trial sub-studyIn: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. Suppl. 6,
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter studyIn: Journal of Clinical Oncology (JCO) Jg. 40 (2022) Nr. Suppl. 6,
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Re: Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection prior to Radical Prostatectomy and Pelvic Lymph Node Dissection : A Multicenter Prospective Phase 3 Imaging TrialIn: The Journal of Urology Jg. 207 (2022) Nr. 4, S. 930
ISSN: 1527-3792; 0022-5347Online Volltext: dx.doi.org/ -
Robuste und lang-andauernde Wirksamkeit der Durvalumab-Konsolidierung bei NSCLC im Stadium III nach Induktionschemotherapie und definitiver Radiochemotherapie : Fokus auf Behandlungsauswahl und prognostische Faktoren
28. Kongress der Deutschen Gesellschaft für Radioonkologie ; DEGRO 2022 ; 26. bis 28.05.2022, Stuttgart, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 198 (2022) Nr. Supplement 1, S. S15
ISSN: 1439-099X; 0179-7158Online Volltext: dx.doi.org/ -
A novel theranostic approach for sarcoma : Insights on diagnostic and therapeutic use of FAP-radioligands
Gemeinsame Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 01.-04. Oktober 2021, Hybrid-Kongress,In: Oncology Research and Treatment Jg. 44 (2021) Nr. Supplement 2, S. 11 - 12
ISSN: 2296-5262; 2296-5270; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Additional Benefit of FDG-PET when Discontinuing Immune Checkpoint Inhibitor Therapy in Patients with metastatic MelanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 75 - 76
ISSN: 1610-0387; 1563-2571; 1610-0379; 0301-0481 -
Complete metabolic response in advanced non-small cell lung cancer patients with prolonged response to immune checkpoint inhibitor therapyIn: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 9050 - 9050
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Development of a novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP) : An international multicenter studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 311 - S312
ISSN: 1619-7070; 1619-7089 -
Dynamic Ga-68-DOTA PET/CT and Compartmental Modelling to Non-invasively Estimate the Glomerular Filtration RateIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1,
ISSN: 0161-5505; 1535-5667 -
EBUS-TBNA and [F-18] FDG-PET/CT for precise Target Volume Definition prior to Chemoradiotherapy : Lymphonodular Spreading Patterns in Stage III NSCLCIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 142
ISSN: 1439-099X; 0179-7158 -
Efficacy and safety of 124-I-MIBG guided high activity 131-I-MIBG therapy of metastatic pheochromocytoma and neuroblastomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290 - S291
ISSN: 1619-7070; 1619-7089 -
Evaluation of Dynamic Renal Ga-68-DOTA PET/CT to Monitor the Urinary Efflux and to Estimate the Glomerular Filtration Rate Using a Compartmental Kinetic Modelling ApproachIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 340
ISSN: 1619-7089; 1619-7070 -
Ga-68-FAPI for sarcoma imaging : Data from the FAPI-PET prospective observational trialIn: Journal of Nuclear Medicine (JNM) Jg. 62 (2021) Nr. Suppl. 1,
ISSN: 0161-5505; 1535-5667 -
Ga-68-versus F-18-PSMA for Cerenkov Luminescence and autoradiography in a prostate cancer mouse modelIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 17
ISSN: 1619-7070; 1619-7089 -
Health-related quality of life (HRQoL), pain and safety outcomes in the phase III VISION study of 177Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancerIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 627 - S628
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ -
Initial clinical experience with [Y-90]Y-FAPI-46 radioligand therapy for advanced stage solid tumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 290
ISSN: 1619-7070; 1619-7089 -
Interim PSMA PET/CT for response evaluation during LuPSMA treatment in mCRPC (INTERIM PET) : An explorative, multicenter studyIn: Journal of Clinical Oncology Jg. 39 (2021) Nr. 15_Suppl, S. 5066 - 5066
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Nomograms to predict outcome after LuPSMA radionuclide therapy in men with metastatic castration-resistant prostate cancer : An international multicenter retrospective studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 63 - S64
ISSN: 1619-7070; 1619-7089 -
PSMA PET and radiomics for the evaluation of liver metastases in castration-resistant prostate cancer patients : A multicenter retrospective studyIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 234
ISSN: 1619-7070; 1619-7089 -
Pain efficacy with radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) in the PARABO observational studyIn: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 641
ISSN: 1569-8041; 0923-7534Online Volltext: dx.doi.org/ -
Pain response and clinical outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) : Final results from a prospective, noninterventional study (PARABO)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 313 - S314
ISSN: 1619-7070; 1619-7089 -
Phase 3 Study of Lu-177-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer (VISION)In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 48 (2021) Nr. Suppl. 1, S. 63
ISSN: 1619-7070; 1619-7089 -
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study ProtocolIn: Cancer Research Jg. 81 (2021) Nr. 13,
ISSN: 1538-7445; 0008-5472 -
Phase III randomized trial of PSMA PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT] : Study protocol NCT04457245In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 6, Supplement, S. TPS172
ISSN: 1527-7755; 0732-183XOnline Volltext: dx.doi.org/ -
Phase III study of lutetium-177-PSMA-617 in patients with metastatic castration-resistant prostate cancer (VISION)
2021 ASCO Annual Meeting II,In: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 18_suppl, S. LBA4 - LBA4
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Prognostic Significance of the metabolic Response during Induction Chemotherapy for the definitive Chemoradiotherapy of locally advanced Squamous Cell Carcinoma of the EsophagusIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics Jg. 197 (2021) Nr. Suppl. 1, S. 154 - S155
ISSN: 1439-099X; 0179-7158 -
Radioembolization with chemotherapy for colorectal liver metastases : A randomized, open-label, international, multicenter, phase III trial (EPOCH study)
ESMO Congress 2021 ; 16 – 21 September 2021, online,In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. S1295
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ (Open Access) -
Visualization of fibroblast activation after myocardial infarction using 68Ga-FAPI-PETIn: European Heart Journal Jg. 42 (2021) Nr. Supplement_1,
ISSN: 0195-668X; 1522-9645Online Volltext: dx.doi.org/ (Open Access) -
18F-FDG -PET/MRI in patients with Graves’ orbitopathy
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S251 - S252
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
18F-Fluorethyltyrosine positron emission tomography versus magnetic resonnace spectroscopy in preoperative detection of newly diagnosed gliomas by using machine learningIn: Neuro-Oncology Jg. 22 (2020) Nr. Supplement 2, S. ii149
ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ -
Accuracy of 68Ga-PSMA-11 for pelvic nodal metastasis detection prior to radical prostatectomy and pelvic lymph node dissection : A multicenter prospective phase III imaging study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S209
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Comparison of Lesion Detectability and Image Quality among Digital and Analog PET Systems for Recurrence in Thyroid Cancer Patients Using I-124
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S429
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Digital high sensitivity I-124 PET/CT improves the detectability of thyroid cancer metastasesIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 255
ISSN: 0161-5505; 1535-5667 -
Early metabolic evaluation using F-18-FDG PET/CT might help to identify patients who benefit from treatment with cdk4/6 inhibitors
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 121 - 122
ISSN: 2296-5270; 2296-5262; 1423-0240; 0378-584XOnline Volltext: dx.doi.org/ -
Effects of anti-TNF-therapy on osteoblastic activity in ankylosing spondylitis : Results from a prospective study using PET-MRI of SIJ and SPINE
EULAR: Annual European Congress of Rheumatology, 2020, 03.-06.06.2020, Frankfurt,In: Annals of the Rheumatic Diseases (ARD) Jg. 79 (2020) Nr. Suppl. 1, S. 1125 - 1126
ISSN: 1468-2060; 0003-4967Online Volltext: dx.doi.org/ -
Efficacy and safety of 177Lu-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S491
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Efficacy and safety of Lu ¹⁷⁷-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : A multicenter retrospective study
2020 ASCO Annual Meeting; 29.05.2020 - 02.06.2020; Chicago, USA,In: Journal of Clinical Oncology (JCO) Jg. 38 (2020) Nr. Suppl. 15, S. e17543
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Efficacy and safety of Lu-177-PSMA radionuclide treatment in patients with diffuse bone marrow involvement : a multicenter retrospective studyIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1284
ISSN: 0161-5505; 1535-5667 -
Emission time optimisation for [68Ga]Ga-PSMA-11 with a SiPM PET/CT based on phantom measurements
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S256
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Emission time reduction for 2-[18F]FDG examinations in lymphoma patients with a PET/CT with SiPM - a feasibility phantom study
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S257 - S258
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Evaluation of 68Ga-PSMA PET/CT Images Acquired with a Reduced Scan Time Duration in Prostate Cancer Patients using a Digital PET/CT Scanner
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S27
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma : results from the prospective, multicenter PETAL and OPTIMAL > 60 trials
Virtuelle Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 09.–11. Oktober 2020,In: Oncology Research and Treatment Jg. 43 (2020) Nr. Suppl. 4, S. 55 - 56
ISSN: 2296-5270; 2296-5262Online Volltext: dx.doi.org/ -
Impact of(68)Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical TrialIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 43
ISSN: 0161-5505; 1535-5667 -
Lymphknoten-Staging von lokal fortgeschrittenen, nicht kleinzelligen Lungenkarzinomen (NSCLC) : Wert von [18F] FDG-PET/CT und EBUS/TBNA zur Festlegung des Zielvolumens bei definitiver Radiotherapie in kurativer IntentionIn: Strahlentherapie und Onkologie Jg. 196 (2020) Nr. S1, S. S143
ISSN: 0179-7158; 1439-099XOnline Volltext: dx.doi.org/ -
Lymphonodular anthracosis in patients undergoing FDG PET/CT for initial lung cancer diagnostics and/or staging is a mayor pitfall : a comparison to the histological gold standard
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S565 - S566
ISSN: 1619-7089; 1619-7070Online Volltext: dx.doi.org/ -
Mapping prostate cancer lesions pre/post unsuccessful salvage lymph node dissection employing PSMA-PETIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1270
ISSN: 0161-5505; 1535-5667 -
Overall survival after177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrate-resistant prostate cancer : Post-hoc analysis of a prospective phase II trial
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S488
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Overall survival after177Lu-PSMA-617 molecular radiotherapy in patients with metastatic castrateresistant prostate cancer : Post-hoc analysis of a prospective phase II trial
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S488
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with PembrolizumabIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 243
ISSN: 0161-5505; 1535-5667 -
PERCIST-derived metabolic volume response predicts overall and progression-free survival in patients with malignant pleural mesothelioma treated with Pembrolizumab
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S353
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
PSMA-PET identifies PCWG3 target populations with high concordance however superior reproducibility when compared to conventional imagingIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 1260
ISSN: 0161-5505; 1535-5667 -
Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal Jg. 41 (2020) Nr. Supplement_2, S. 3260
ISSN: 0195-668X; 1522-9645Online Volltext: dx.doi.org/ -
Predictive factors and prediction nomograms for LuPSMA radioligand therapy in patients with metastatic castration-resistant prostate cancer : an international multicentre retrospective studyIn: Journal of Nuclear Medicine (JNM) Jg. 61 (2020) Nr. Suppl. 1, S. 593
ISSN: 0161-5505; 1535-5667 -
Preliminary Investigations on Radiation Exposure in [68Ga]Ga-PSMA-11 based Cerenkov Luminescence Imaging Procedures
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S212
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancerIn: Journal of Clinical Oncology Jg. 38 (2020) Nr. 15_Suppl., S. 5548
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Prognostic markers for overall survival and outcome to LuPSMA radionuclide treatment in patients with metastatic castration-resistant prostate cancer
EANM‘20 ; Annual Congress of the European Association of Nuclear Medicine ; October 22 – 30, 2020, Wien, Virtual,In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 47 (2020) Nr. Supplement 1, S. S487
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Volumetric PET response assessment outperforms conventional criteria in patients receiving high-dose pembrolizumab for malignant mesothelioma
ESMO Virtual Congress 2020, 19.-21.09- und 16.-18.10.2020,In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S1076 - S1077
ISSN: 0923-7534; 1569-8041Online Volltext: dx.doi.org/ -
RESIST-PC phase 2 trial : 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancerIn: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 15, S. 5028 - 5028
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Role of FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Aggressive Non-Hodgkin Lymphoma
Konferenz 61st ASH (American Society of Hematology) Annual Meeting & Exposition; Dec 07 - 10 2019; Oralndo, USA,In: Blood Jg. 134 (2019) Nr. Supplement_1, S. 2892 - 2892
ISSN: 0006-4971; 1528-0020Online Volltext: dx.doi.org/ -
A whole blood gene expression signature accurately diagnoses multiple myeloma and differentiates patients in remission from those with active and progressive disease
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie ; 28. September - 2. Oktober 2018, Wien,In: Oncology Research and Treatment Jg. 41 (2018) Nr. Suppl. 4, S. 231
ISSN: 2296-5262; 2296-5270Online Volltext: dx.doi.org/ -
Accuracy of 68Ga-PSMA11 PET/CT on recurrent prostate cancer : Preliminary results from a phase 2/3 prospective trialIn: Journal of Clinical Oncology (JCO) Jg. 36 (2018) Nr. Suppl. 15, S. 5001 - 5001
ISSN: 0732-183X; 1527-7755Online Volltext: dx.doi.org/ -
Ascertaining F18 positron-emission tomography skill in glioma classification pursuant to the revised WHO classification 2016In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 354 - S355
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
BRAF Mutation Analysis for Initial Risk Stratification in High Risk Papillary Thyroid CarcinomaIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 551
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Comparison evaluation of the diagnostic potential of PET/MRI and PET/CT using mIBG-Iod-124 in neuroendocrine and neuroectodermal tumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 65
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Comparison of 68Ga-PSMA-11 PET/CT and F-18-Fluciclovine PET/CT in recurrent Prostate CancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 150
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Correction of radiation induced stunning (CRIS) in pretherapeutic radioiodine-131 uptake test of patients suffering from goiterIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 420
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Correlation of immunohistochemical parameters, apparent diffusion coefficient (ADC) and standardized uptake value (SUV) in lung cancer using hybrid PET/MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 176
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Development and Characterization of a PSMA-targeting Antibody for SPECT/CT, Fluorescence Imaging and Targeted Photodynamic Therapy of PSMA-expressing TumorsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 39 - S40
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Extrahepatic Comorbidities Do Not Alter the Safety and Efficacy of Radioembolization of NAFLD-Associated HCCIn: Hepatology Jg. 68 (2018) Nr. S1, S. 852A - 853A
ISSN: 0270-9139Online Volltext: dx.doi.org/ -
Inflammation focus search with 18F-FDG-PET/MRI: comparative or additive value of PET and MRIIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 259 - S260
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
Intraindividual comparison of subsequently performed PET/MRI to PET/CT for whole-body staging : Results of a unicenter trial in 1000 patientsIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 210 - S211
ISSN: 1619-7089Online Volltext: dx.doi.org/ -
NIMG-32. COMPARISON OF L-METHYL-11C-METHIONINE POSITRON EMISSION TOMOGRAPHY WITH MAGNETIC RESONANCE SPECTROSCOPY IN DETECTING NEWLY DIAGNOSED GLIOMA
23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, USA,In: Neuro-Oncology Jg. 20 (2018) Nr. suppl_6, S. vi182 - vi183
ISSN: 1522-8517; 1523-5866Online Volltext: dx.doi.org/ -
Prospective comparison of F-18-FDG PET/MRI and F-18-FDG PET/CT for thoracic staging of non-small cell lung cancerIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. S502 Abstract EP-0517
ISSN: 1619-7070; 1619-7089; 0340-6997; 1432-105XOnline Volltext: dx.doi.org/ -
Radiation induced stunning in patients suffering from benign thyroid diseases due to pre-therapeutic radioiodine-131 uptake testIn: European Journal of Nuclear Medicine and Molecular Imaging Jg. 45 (2018) Nr. Suppl. 1, S. 351 - S352
ISSN: 1619-7070; 1619-7089Online Volltext: dx.doi.org/ -
Proton Beam Range Verification with Secondary Radiation from Titanium ImplantsIn: 2019 IEEE Nuclear Science Symposium and Medical Imaging Conference, NSS/MIC 2019 / IEEE Nuclear Science Symposium 2019 Manchester, 26 Oct.-2 Nov. 2019 2019
ISBN: 9781728141640Online Volltext: dx.doi.org/ -
Current and emerging applicationsIn: PET/MR Imaging: Current and Emerging Applications / Umutlu, Lale; Herrmann, Ken (Hrsg.) 2018, S. 1 - 8
ISBN: 9783319696416; 9783319696409Online Volltext: dx.doi.org/ -
Lung CancerIn: PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging / Beheshti, Mohsen; Langsteger, Werner; Rezaee, Alireza (Hrsg.) 2018, S. 23 - 42
ISBN: 978-0-323-49608-7; 978-0-323-48567-8Online Volltext: dx.doi.org/ -
PET/MR Imaging : Current and Emerging ApplicationsCham (2018)
ISBN: 9783319696416; 9783319696409Online Volltext: dx.doi.org/